Adalimumab Biosimilar Market Trends Archives

Adalimumab Biosimilar Market: Deep Dive into Growth, Trends 2032

The adalimumab biosimilar market is projected to grow at a remarkable CAGR of 17.60% from 2024 to 2032. This growth is propelled

Adalimumab, originally developed by AbbVie under the brand name Humira, is a monoclonal antibody used to treat various autoimmune diseases,